2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists

The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described. These compounds are structurally simple and display appropriate physical properties for CNS agents The discovery, synthesis and structure–activity studies o...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2003-08, Vol.13 (15), p.2497-2500
Main Authors: Hodgetts, Kevin J., Yoon, Taeyoung, Huang, Jianhua, Gulianello, Michael, Kieltyka, Andrzej, Primus, Renee, Brodbeck, Robbin, De Lombaert, Stéphane, Doller, Darı́o
Format: Article
Language:English
Subjects:
Biological and medical sciences
Chemical Phenomena
Chemistry, Physical
Drug Design
Humans
In Vitro Techniques
Indicators and Reagents
Medical sciences
Microsomes - drug effects
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Pyrimidines - chemical synthesis
Pyrimidines - pharmacology
Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors
Structure-Activity Relationship
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c391t-8be4e0f2fc920fc1a98ff4605cf79f28f6d0f84399f152e8cabd37749dd9d6b43
cites cdi_FETCH-LOGICAL-c391t-8be4e0f2fc920fc1a98ff4605cf79f28f6d0f84399f152e8cabd37749dd9d6b43
container_end_page 2500
container_issue 15
container_start_page 2497
container_title Bioorganic & medicinal chemistry letters
container_volume 13
creator Hodgetts, Kevin J.
Yoon, Taeyoung
Huang, Jianhua
Gulianello, Michael
Kieltyka, Andrzej
Primus, Renee
Brodbeck, Robbin
De Lombaert, Stéphane
Doller, Darı́o
description The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described. These compounds are structurally simple and display appropriate physical properties for CNS agents The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described.
doi_str_mv 10.1016/S0960-894X(03)00483-9
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73465399</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X03004839</els_id><sourcerecordid>73465399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-8be4e0f2fc920fc1a98ff4605cf79f28f6d0f84399f152e8cabd37749dd9d6b43</originalsourceid><addsrcrecordid>eNqFkEtLJDEURoM4aOv4E5TaKCOY8aaSemQljfgYEGYxNrgL6eRGotVJm1QL_e-n-qEuXd27ON99HEKOGfxmwOrLfyBroK0UT7-AnwOIllO5Q0ZM1IJyAdUuGX0i--Qg5xcAJkCIPbLPyrYqZcVGZFLScVp2lF_U1HrdvQ599dHpmQ9xvkx-5q0PVNAYMBc6FyG-Y1eY5CgrEhqc9zEVOvT6OQaf-_yT_HC6y3i0rYdkcnvzeH1PH_7e_bkeP1DDJetpO0WB4EpnZAnOMC1b50QNlXGNdGXraguuFVxKx6oSW6OnljeNkNZKW08FPyRnm7nzFN8WmHs189lg1-mAcZFVw0VdDfEBrDagSTHnhE7Nh690WioGauVTrX2qlSwFXK19qlXuZLtgMZ2h_UptBQ7A6RbQ2ejOJR2Mz1-ckA1jzWrQ1YbDQce7x6Sy8RgMWj8I7JWN_ptT_gNG-5JL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73465399</pqid></control><display><type>article</type><title>2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists</title><source>ScienceDirect Freedom Collection</source><creator>Hodgetts, Kevin J. ; Yoon, Taeyoung ; Huang, Jianhua ; Gulianello, Michael ; Kieltyka, Andrzej ; Primus, Renee ; Brodbeck, Robbin ; De Lombaert, Stéphane ; Doller, Darı́o</creator><creatorcontrib>Hodgetts, Kevin J. ; Yoon, Taeyoung ; Huang, Jianhua ; Gulianello, Michael ; Kieltyka, Andrzej ; Primus, Renee ; Brodbeck, Robbin ; De Lombaert, Stéphane ; Doller, Darı́o</creatorcontrib><description>The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described. These compounds are structurally simple and display appropriate physical properties for CNS agents The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(03)00483-9</identifier><identifier>PMID: 12852951</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Chemical Phenomena ; Chemistry, Physical ; Drug Design ; Humans ; In Vitro Techniques ; Indicators and Reagents ; Medical sciences ; Microsomes - drug effects ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Pyrimidines - chemical synthesis ; Pyrimidines - pharmacology ; Receptors, Corticotropin-Releasing Hormone - antagonists &amp; inhibitors ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2003-08, Vol.13 (15), p.2497-2500</ispartof><rights>2003 Elsevier Science Ltd</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-8be4e0f2fc920fc1a98ff4605cf79f28f6d0f84399f152e8cabd37749dd9d6b43</citedby><cites>FETCH-LOGICAL-c391t-8be4e0f2fc920fc1a98ff4605cf79f28f6d0f84399f152e8cabd37749dd9d6b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14971179$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12852951$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hodgetts, Kevin J.</creatorcontrib><creatorcontrib>Yoon, Taeyoung</creatorcontrib><creatorcontrib>Huang, Jianhua</creatorcontrib><creatorcontrib>Gulianello, Michael</creatorcontrib><creatorcontrib>Kieltyka, Andrzej</creatorcontrib><creatorcontrib>Primus, Renee</creatorcontrib><creatorcontrib>Brodbeck, Robbin</creatorcontrib><creatorcontrib>De Lombaert, Stéphane</creatorcontrib><creatorcontrib>Doller, Darı́o</creatorcontrib><title>2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described. These compounds are structurally simple and display appropriate physical properties for CNS agents The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described.</description><subject>Biological and medical sciences</subject><subject>Chemical Phenomena</subject><subject>Chemistry, Physical</subject><subject>Drug Design</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Indicators and Reagents</subject><subject>Medical sciences</subject><subject>Microsomes - drug effects</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - pharmacology</subject><subject>Receptors, Corticotropin-Releasing Hormone - antagonists &amp; inhibitors</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkEtLJDEURoM4aOv4E5TaKCOY8aaSemQljfgYEGYxNrgL6eRGotVJm1QL_e-n-qEuXd27ON99HEKOGfxmwOrLfyBroK0UT7-AnwOIllO5Q0ZM1IJyAdUuGX0i--Qg5xcAJkCIPbLPyrYqZcVGZFLScVp2lF_U1HrdvQ599dHpmQ9xvkx-5q0PVNAYMBc6FyG-Y1eY5CgrEhqc9zEVOvT6OQaf-_yT_HC6y3i0rYdkcnvzeH1PH_7e_bkeP1DDJetpO0WB4EpnZAnOMC1b50QNlXGNdGXraguuFVxKx6oSW6OnljeNkNZKW08FPyRnm7nzFN8WmHs189lg1-mAcZFVw0VdDfEBrDagSTHnhE7Nh690WioGauVTrX2qlSwFXK19qlXuZLtgMZ2h_UptBQ7A6RbQ2ejOJR2Mz1-ckA1jzWrQ1YbDQce7x6Sy8RgMWj8I7JWN_ptT_gNG-5JL</recordid><startdate>20030804</startdate><enddate>20030804</enddate><creator>Hodgetts, Kevin J.</creator><creator>Yoon, Taeyoung</creator><creator>Huang, Jianhua</creator><creator>Gulianello, Michael</creator><creator>Kieltyka, Andrzej</creator><creator>Primus, Renee</creator><creator>Brodbeck, Robbin</creator><creator>De Lombaert, Stéphane</creator><creator>Doller, Darı́o</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030804</creationdate><title>2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists</title><author>Hodgetts, Kevin J. ; Yoon, Taeyoung ; Huang, Jianhua ; Gulianello, Michael ; Kieltyka, Andrzej ; Primus, Renee ; Brodbeck, Robbin ; De Lombaert, Stéphane ; Doller, Darı́o</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-8be4e0f2fc920fc1a98ff4605cf79f28f6d0f84399f152e8cabd37749dd9d6b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Biological and medical sciences</topic><topic>Chemical Phenomena</topic><topic>Chemistry, Physical</topic><topic>Drug Design</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Indicators and Reagents</topic><topic>Medical sciences</topic><topic>Microsomes - drug effects</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - pharmacology</topic><topic>Receptors, Corticotropin-Releasing Hormone - antagonists &amp; inhibitors</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hodgetts, Kevin J.</creatorcontrib><creatorcontrib>Yoon, Taeyoung</creatorcontrib><creatorcontrib>Huang, Jianhua</creatorcontrib><creatorcontrib>Gulianello, Michael</creatorcontrib><creatorcontrib>Kieltyka, Andrzej</creatorcontrib><creatorcontrib>Primus, Renee</creatorcontrib><creatorcontrib>Brodbeck, Robbin</creatorcontrib><creatorcontrib>De Lombaert, Stéphane</creatorcontrib><creatorcontrib>Doller, Darı́o</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hodgetts, Kevin J.</au><au>Yoon, Taeyoung</au><au>Huang, Jianhua</au><au>Gulianello, Michael</au><au>Kieltyka, Andrzej</au><au>Primus, Renee</au><au>Brodbeck, Robbin</au><au>De Lombaert, Stéphane</au><au>Doller, Darı́o</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2003-08-04</date><risdate>2003</risdate><volume>13</volume><issue>15</issue><spage>2497</spage><epage>2500</epage><pages>2497-2500</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described. These compounds are structurally simple and display appropriate physical properties for CNS agents The discovery, synthesis and structure–activity studies of a novel series of 2-arylpyrimidin-4-ones as CRF-1 receptor antagonists is described.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12852951</pmid><doi>10.1016/S0960-894X(03)00483-9</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2003-08, Vol.13 (15), p.2497-2500
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_73465399
source ScienceDirect Freedom Collection
subjects Biological and medical sciences
Chemical Phenomena
Chemistry, Physical
Drug Design
Humans
In Vitro Techniques
Indicators and Reagents
Medical sciences
Microsomes - drug effects
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Pyrimidines - chemical synthesis
Pyrimidines - pharmacology
Receptors, Corticotropin-Releasing Hormone - antagonists & inhibitors
Structure-Activity Relationship
title 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A20%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones%20as%20novel%20crf-1%20receptor%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Hodgetts,%20Kevin%20J.&rft.date=2003-08-04&rft.volume=13&rft.issue=15&rft.spage=2497&rft.epage=2500&rft.pages=2497-2500&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(03)00483-9&rft_dat=%3Cproquest_cross%3E73465399%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c391t-8be4e0f2fc920fc1a98ff4605cf79f28f6d0f84399f152e8cabd37749dd9d6b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73465399&rft_id=info:pmid/12852951&rfr_iscdi=true